Hotbed/Location
Filter News
Found 736,789 articles
-
Bausch & Lomb Storz(R) Ophthalmics Introduces New Collection of StableGrip(TM) Vitreoretinal Instruments
6/1/2011
-
Align Technology, Inc. Announces Commercial Availability of Invisalign in China
6/1/2011
-
Shield Therapeutics Raises EUR8.2 Million From Inventages Venture Capital Via Series A Institutional Round
6/1/2011
-
Enerkem Raises $60 Million in Latest Financing Round
6/1/2011
-
EndoSphere Inc. Announces Pivotal Financing Led by Broadline Capital
6/1/2011
-
General Electric Company Furthers Investment in RIS with Latest Release
6/1/2011
-
MorphoSys AG to Start Share Buy-Back Program
6/1/2011
-
BIOLASE Technology, Inc. Declares Stock Dividend for 2011 Second Quarter
6/1/2011
-
Maxygen, Inc. Announces $10 Million Stock Repurchase Program
6/1/2011
-
Poniard Pharmaceuticals, Inc. Board of Directors Urges Shareholders to Vote
6/1/2011
-
Syneron Medical Ltd. Terminates Shareholder Rights Plan
6/1/2011
-
Evogene Ltd. Announces Exercise of the Company's Series 2 Warrants
6/1/2011
-
Generex Biotechnology Corporation Announces Intention to Dividend a Portion of Anticipated Amarantus BioSciences Shares to Its Shareholders upon a Reverse Stock Split
6/1/2011
-
Complete Genomics, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option
6/1/2011
-
Alere Inc. Announces Commencement of Consent Solicitations Related to its 9.0% Senior Subordinated Notes due 2016, 8.625% Senior Subordinated Notes due 2018 and 7.875% Senior Notes due 2016
6/1/2011
-
Cell Therapeutics, Inc. Regains Compliance with NASDAQ Minimum Bid Price Rule
6/1/2011
-
ConforMIS Announces Completion of the First iTotal(R) CR Knee Resurfacing System Surgeries
6/1/2011
-
MIM Software's Medical Imaging App for Patients, VueMe, Now Available on iPad, iPhone, and iPod Touch
6/1/2011
-
BioLife Solutions, Inc. Announces Expanded Customer Base in the High Growth Regenerative Medicine Market
6/1/2011
-
Orexigen Therapeutics, Inc. Schedules June 3, 2011 Webcast and Conference Call to Provide a Regulatory Update on Contrave® NDA
6/1/2011